首页> 外文OA文献 >A phase II, multicenter, randomized, double-blind, placebo-controlled trial of the safety and efficacy of velafermin (CG53135-05) administered intravenously as a single dose for the prevention of oral mucositis in patients receiving autologous hematopoietic stem cell transplant (AHSCT)

【2h】

A phase II, multicenter, randomized, double-blind, placebo-controlled trial of the safety and efficacy of velafermin (CG53135-05) administered intravenously as a single dose for the prevention of oral mucositis in patients receiving autologous hematopoietic stem cell transplant (AHSCT)

机译：velafermin（CG53135-05）的安全性和有效性作为单剂量静脉注射用于预防自体造血干细胞移植（AHSCT）患者的口腔粘膜炎的II期，多中心，随机，双盲，安慰剂对照试验）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Anaissie E.; Schuster M.W.; Hurd D.; Bensinger W.; Mason J.; McCarty J.M.; Rifkin R.; Maziarz R.; Bolwell B.; Mehta J.; Mangan K.; Skikne B.; Abboud C.; Chao N.; Stadtmauer E.; Fernandez H.; Lazarus H.; Westervelt P.; Halvorsen Y.; Gerwien R.; Annino V.; Hahne W.;
展开▼
作者单位

展开▼
年度 2006
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation [J] . Mark M. Schubert, Fernanda P. Eduardo, Katherine A. Guthrie, Supportive Care in Cancer . 2007,第10期

机译：一项III期随机双盲安慰剂对照临床试验，旨在确定低水平激光疗法对造血细胞移植患者口腔粘膜炎的预防作用
2. Abstract of the 20th International Anniversary MASCC/ISOO Symposium: A Phase III randomized double-blind placebo controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation [J] . M. M. Schubert, F. P. Eduardo, K. A. Guthrie, Supportive Care in Cancer . 2007,第11期

机译：第20届国际MASCC / ISOO周年研讨会摘要：一项III期随机双盲安慰剂对照临床试验，旨在确定低水平激光疗法对造血细胞移植患者口腔粘膜炎的预防作用
3. Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant [J] . Michael W. Schuster, Tsiporah B. Shore, John G. Harpel, Supportive Care in Cancer . 2008,第5期

机译：Velafermin（CG53135-05）在接受大剂量化疗和自体外周血干细胞移植的患者中的安全性和耐受性
4. HIGH DOSE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) FOR PATIENTS WITH PRIMARY SYSTEMIC AMYLOIDOSIS (AL): AN ABMTR STUDY [C] . DH Vesole, W Perez, D Reece, International Symposium on Amyloidosis . 2005

机译：具有自体造血干细胞移植（HSCT）的高剂量治疗用于初级全身淀粉样蛋白症（AL）的患者：ABMTR研究
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre randomised double-blind placebo-controlled phase 3 trial [O] . H. Saito, H. Yoshizawa, K. Yoshimori, -1

机译：单剂量福沙普瑞汀预防大剂量顺铂患者化疗引起的恶心和呕吐的有效性和安全性：一项多中心随机双盲安慰剂对照的3期试验
7. A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of Inactivated Vzv Vaccine (ZVIN) in Recipients of Autologous Hematopoietic Cell Transplants (Auto-Hcts) [O] . Drew J. Winston, Kathleen M. Mullane, Michael J. Boeckh, 2017

机译：III期，双盲，随机，安慰剂控制的多中心临床试验，用于研究自体造血细胞移植受体（自动HCTS）中的灭活VZV疫苗（Zvin）的安全性，耐受性，疗效和免疫原性（Auto-Hcts）

A phase II, multicenter, randomized, double-blind, placebo-controlled trial of the safety and efficacy of velafermin (CG53135-05) administered intravenously as a single dose for the prevention of oral mucositis in patients receiving autologous hematopoietic stem cell transplant (AHSCT)

著录项

引文网络

相似文献

相关主题

期刊订阅